Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
APPLICATION OF FAVIPIRAVIR IN TREATING CORONAVIRUS INFECTION
Document Type and Number:
WIPO Patent Application WO/2021/147235
Kind Code:
A1
Abstract:
The present application relates to a favipiravir compound as represented by formula I, a pharmaceutically acceptable salt and/or a solvate and/or a hydrate thereof, and a pharmaceutical composition containing the compound, used for treating coronavirus infection.

Inventors:
ZHONG WU (CN)
CAO RUIYUAN (CN)
CAO CHENG (CN)
GAO TING (CN)
XIAO GENGFU (CN)
HU ZHIHONG (CN)
WANG MANLI (CN)
ZHANG LEIKE (CN)
LI SONG (CN)
Application Number:
PCT/CN2020/097395
Publication Date:
July 29, 2021
Filing Date:
June 22, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ACAD OF MILITARY MEDICAL SCIENCES (CN)
International Classes:
A61K31/4965; A61P11/00; A61P31/14
Foreign References:
CN111557939A2020-08-21
CN111265528A2020-06-12
CN102655859A2012-09-05
CN107072976A2017-08-18
CN1418220A2003-05-14
CN107737128A2018-02-27
CN102655859A2012-09-05
Other References:
LIU KUIKUI, DENG YUXIAO;FENG JING;WANG LING: "Determination of the Ｒelated Substances in Favipiravir by HPLC", ZHONGGUO YAOSHI - CHINA PHARMACIST, YAOWU LIUXINGBINGXUE ZAZHISHE, HUBEI, CN, vol. 21, no. 4, 1 January 2018 (2018-01-01), CN, pages 739 - 742, XP055831584, ISSN: 1008-049X
FURUTA YOUSUKE; GOWEN BRIAN B.; TAKAHASHI KAZUMI; SHIRAKI KIMIYASU; SMEE DONALD F.; BARNARD DALE L.: "Favipiravir (T-705), a novel viral RNA polymerase inhibitor", ANTIVIRAL RESEARCH, ELSEVIER BV, NL, vol. 100, no. 2, 29 September 2013 (2013-09-29), NL, pages 446 - 454, XP028763316, ISSN: 0166-3542, DOI: 10.1016/j.antiviral.2013.09.015
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: BACTERICIDAL PLASTIC MASTERBATCH, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF

Next Patent: USE OF SUBSTITUTED AMINOPROPIONATE COMPOUND IN TREATMENT OF SARS-COV-2 INFECTIONS